No Evidence of Abnormal Expression of Beta-Catenin and Bcl-2 Proteins in Pilomatricoma as One Clinical Feature of Tetrasomy 9p Syndrome
Authors:
- Chariyawan CharalsawadiCCChariyawan Charalsawadi
- Sasipong TrongnitSTSasipong Trongnit
- Kanoot JaruthamsophonKJKanoot Jaruthamsophon
- Juthamas WirojananJWJuthamas Wirojanan
- Somchit JaruratanasirikulSJSomchit Jaruratanasirikul
- Anupong NitiruangjarasANAnupong Nitiruangjaras
- Pornprot LimprasertPLPornprot Limprasert
Open Access
- 15 December 2021
- journal article
- research article
- Published by Wiley in International Journal of Pediatrics
- Vol. 2021, 1-8
Abstract
Background. Little is currently known about the genetics of pilomatricoma. A number of studies have reported some evidence that this disease may have a genetic association with mutations of CTNNB1 gene or expression of the beta-catenin protein. In this study, we reviewed literatures involving 30 patients with various genetic syndromes that have been linked to pilomatricoma and found that somatic mutations of the CTNNB1 gene were reported in 67 of patients. Pilomatricoma has been reported in patients with chromosome 9 rearrangements, including 4 patients with tetrasomy 9p syndrome and one patient with partial trisomy 9. In addition to beta-catenin, the expression of bcl2 was observed in pilomatricoma. Objectives. To report an additional case of tetrasomy 9p syndrome with concurrent pilomatricoma and to examine whether abnormal protein expressions of the CTNNB1 and/or BCL2 genes were present. Methods. Cytogenetic analysis was carried out on peripheral blood, biopsied skin, and pilomatricoma tissue obtained from a patient with tetrasomy 9p syndrome. Immunohistochemical staining was performed on the pilomatricoma tissue, using beta-catenin and bcl2 monoclonal antibodies. Results. SNP microarray revealed nonmosaic gain of the short arm of chromosome 9. A nonmosaic isodicentric chromosome 9 was identified in the peripheral blood but this rearranged chromosome was detected in only 8.3 of the skin fibroblasts. Chromosomal abnormalities were not detected in the pilomatricoma nor expression of beta-catenin or bcl2 proteins in our patient. Conclusion. Pilomatricoma could be a new clinical feature associated with tetrasomy 9p syndrome; however, we found no evidence of tetrasomy 9p or abnormal beta-catenin or bcl2 proteins of the CTNNB1 and BCL2 genes in our pilomatricoma patient.Keywords
Funding Information
- Faculty of Medicine, Prince of Songkla University
This publication has 51 references indexed in Scilit:
- Giant pilomatricoma in a patient with tuberous sclerosis, both diagnosed in the adult lifeBMJ Case Reports, 2013
- Trisomy 18 is a consistent cytogenetic feature in pilomatricomaLaboratory Investigation, 2010
- Anetodermic pilomatricoma in a patient with tuberous sclerosisClinical and Experimental Dermatology, 2009
- Multiple Pilomatricomas in Association with Trisomy 9Pediatric Dermatology, 2009
- Pilomatricomas in Turner SyndromePediatric Dermatology, 2008
- Multiple Giant Pilomatricoma in Familial Sotos SyndromePediatric Dermatology, 2008
- A kindred withMYH-associated polyposis and pilomatricomasAmerican Journal of Medical Genetics Part A, 2005
- beta-catenin expression in benign and malignant pilomatrix neoplasmsBritish Journal of Dermatology, 2004
- Two Cases of Pilomatrixoma in Turner’s SyndromeDermatology, 1999
- Multiple Familial Pilomatricomas: A Cutaneous Marker for Gardner Syndrome?Pediatric Dermatology, 1995